505
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence of Multidrug-Resistant TB Among Smear-Positive Pulmonary TB Patients in Banadir, Somalia: A Multicenter Study

ORCID Icon, , , , , & ORCID Icon show all
Pages 7241-7248 | Received 16 Aug 2022, Accepted 05 Dec 2022, Published online: 10 Dec 2022

References

  • World Health Organization. Global Tuberculosis Report [Internet]; 2021. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021. Accessed December 5, 2022.
  • World Health Organization (WHO). WHO Report on TB 2020 [Internet]. Vol. 1. World Health Organization; 2020.
  • World Health Organization (WHO). Operational handbook on tuberculosis [Internet]. WHO operational handbook on tuberculosis Module 5; 2022. 45. Available from: https://apps.who.int/iris/bitstream/handle/10665/340256/9789240022614-eng.pdf. Accessed December 5, 2022.
  • Tembo BP, Malangu NG. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana. BMC Infect Dis. 2019;19(1):1–8. doi:10.1186/s12879-019-4375-7
  • Rudnicka E, Napiera P, Pod A, Smolarczyk R, Grymowicz M. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company’s public news and information; 2020.
  • Howard NC, Khader SA. Immunometabolism during Mycobacterium tuberculosis Infection. Trends Microbiol. 2020;28(10):832–850. doi:10.1016/j.tim.2020.04.010
  • Li Q, Zhao G, Wu L, et al. Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China. Antimicrob Resist Infect Control. 2018;7(1):4–9. doi:10.1186/s13756-018-0348-7
  • Boyer-Cazajous G, Martinaud C, Déhan C, et al. High prevalence of multidrug resistant tuberculosis in Djibouti: a retrospective study. J Infect Dev Ctries. 2014;8(2):233–236. doi:10.3855/jidc.3837
  • Sindani I, Fitzpatrick C, Falzon D, et al. Multidrug- Resistant. Emerg Infect Dis. 2013;19(3):1–3. doi:10.3201/eid1901.120393
  • Yao C, Guo H, Li Q, et al. Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition. Antimicrob Resist Infect Control. 2021;10(1):1–8. doi:10.1186/s13756-021-00995-8
  • Dirie AMH, Özdemir H, Hussein AM, Warsame AM. Empyema necessitans mimicking mesothelioma; unusual presentation of active pulmonary TB in immuno-competent state. Ann Med Surg. 2022;1:75.
  • World Health Organization. Global Tuberculosis Report 2021 [Internet]. Geneva: World Health Organization; 2021. Available from. https://www.who.int/publications/i/item/9789240037021. Accessed December 5, 2022.
  • Otieno OC, Nyamache AK, Nonoh J, Amukoye E. Prevalence and detection of drug resistant mutations in mycobacterium tuberculosis among patients visiting selected health centres in Nairobi, Kenya. BMC Infect Dis. 2018;19:1–7.
  • Kateregga NJ, Atuheire C, Ntambi S, Ocaka D, Ndukui GJ, Wampande E. Prevalence of multidrug resistant mycobacterium tuberculosis and risk factors among youth attending MDR-TB unit in mulago hospital. J Bacteriol Mycol. 2018;5(9):1088.
  • Timire C, Metcalfe JZ, Chirenda J, et al. Prevalence of drug-resistant tuberculosis in Zimbabwe: a health facility-based cross-sectional survey. Int J Infect Dis. 2019;87:119–125. doi:10.1016/j.ijid.2019.07.021
  • Diriba G, Kebede A, Tola HH, et al. Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia. Infect Dis Poverty. 2019;8(1):4–9. doi:10.1186/s40249-019-0554-4
  • Sinshaw W, Kebede A, Bitew A, et al. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia. BMC Infect Dis. 2019;19(1):1–15. doi:10.1186/s12879-019-4241-7
  • Sylverken AA, Kwarteng A, Twumasi-Ankrah S, et al. The burden of drug resistance tuberculosis in Ghana; results of the First National Survey. PLoS One. 2021;16(6):1–14. doi:10.1371/journal.pone.0252819
  • Lv XT, Lu XW, Shi XY, Zhou L. Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China. J Int Med Res. 2017;45(6):1779–1786. doi:10.1177/0300060516687429
  • He GX, Zhao YL, Jiang GL, et al. Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect Dis. 2008;8:1–8. doi:10.1186/1471-2334-8-166
  • Sambas MFMK, Rabbani U, Al-Gethamy MMM, et al. Prevalence and determinants of multidrug-resistant tuberculosis in Makkah, Saudi Arabia. Infect Drug Resist. 2020;13:4031–4038. doi:10.2147/IDR.S277477
  • Emam SA, Kasem EM, Sedhom AE. Characteristics of multidrug resistant tuberculosis in minia, Egypt. Medico Legal Updat. 2020;20(1):446–452.
  • Welekidan LN, Skjerve E, Dejene TA, et al. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: a cross-sectional study. PLoS One. 2020;15(8):1–20. doi:10.1371/journal.pone.0236362
  • Dirie AMH The prevalence of HIV among tuberculosis patients in Benadir, Somalia. Retrospective multi-center study The prevalence of HIV among tuberculosis patients in Benadir. Somalia: Retrospective multi-center study; 2022.